Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial

Ragnhild Røysland; Serge Masson; Torbjørn Omland; Valentina Milani; Mette Bjerre; Allan Flyvbjerg; Giuseppe Di Tano; Gianfranco Misuraca; Aldo Maggioni; Gianni Tognoni; Luigi Tavazzi; Roberto Latini

doi:10.1016/j.ahj.2010.05.015

Related publications

Article2020

Cancer in chronic heart failure patients in the GISSI‐HF trial

Pietro Ameri, Marco Canepa, Gian Luigi Nicolosi, Roberto Marchioli, Roberto Latini, Luigi Tavazzi, Aldo Maggioni

Article2010

The Predictive Value of Stable Precursor Fragments of Vasoactive Peptides in Patients with Chronic Heart Failure: Data from the GISSI-Heart Failure (GISSI-HF) Trial

Serge Masson, Roberto Latini, Emanuele Carbonieri, Luciano Moretti, Maria Grazia Rossi, S. Ciricugno, Valentina Milani, Roberto Marchioli, Joachim Struck, Andreas Bergmann, Aldo Maggioni, Gianni Tognoni, Luigi Tavazzi

Article2017

Clinical and prognostic value of spot urinary creatinine in chronic heart failure—An analysis from GISSI-HF

Jozine M. ter Maaten, Aldo Maggioni, Roberto Latini, Serge Masson, Gianni Tognoni, Luigi Tavazzi, Stefano Signorini, Adriaan A. Voors, Kevin Damman

Article2014

Prognostic impact of metabolic syndrome in patients with chronic heart failure: Data from GISSI-HF trial

Pasquale Perrone Filardi, Gianluigi Savarese, Marco Scarano, Riccardo Cavazzina, Bruno Trimarco, Sergio Minneci, Aldo Maggioni, Luigi Tavazzi, Gianni Tognoni, Roberto Marchioli

Article2009

Abstract 3477: Prognostic Value and Serial Changes of Plasma Adiponectin Concentration in Patients With Chronic Heart Failure. Data From the GISSI-HF Trial

Serge Masson, Torbjørn Omland, Roberto Latini, Allan Flyvbjerg, Valentina Milani, Jan Frystyk, Angiolina Pasini, Patrizio Sarto, Tarcisio Vago, Aldo Maggioni, Gianni Tognoni, Luigi Tavazzi